Problem statement: Answer the multiple-choice question.
Question: Which drug has a 18.432% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. CC(C)(C)C(=O)NC1(C(F)(F)F)NC(=O)N(Cc2ccccc2)C1=O
b. CC1N(C)c2cc(NC(=O)c3cccs3)c(P(=O)(Nc3ccc([N+](=O)[O-])cc3)N3CCOCC3)cc2C1(C)C
Answer: a. CC(C)(C)C(=O)NC1(C(F)(F)F)NC(=O)N(Cc2ccccc2)C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)(C)C(=O)NC1(C(F)(F)F)NC(=O)N(Cc2ccccc2)C1=O
CC(C)(C)C(=O)NC1(C(F)(F)F)NC(=O)N(Cc2ccccc2)C1=O
N-[1-benzyl-2,5-dioxo-4-(trifluoromethyl)imidazolidin-4-yl]-2,2-dimethylpropanamide